Levine Keszler advises Ennov on its acquisition of Calyx’s Enterprise Technology Division

Ennov, provider of the only unified compliance platform for life sciences, has announced the strategic acquisition of the ‘Enterprise Technology’ division of Calyx.

This acquisition aligns seamlessly with Ennov’s overarching strategy of delivering the sole unified, robust, and cost-effective cloud-based platform for compliance solutions, spanning quality, regulatory, pharmacovigilance, clinical, and transparency management within the life sciences market.

With this transaction, Ennov is poised to offer an expanded array of solutions aimed at driving efficiency, ensuring compliance, and fostering innovation for life sciences organizations worldwide.

Levine Keszler advised Ennov and its subsidiaries on this transaction.

Advisors for Ennov:
Global transactional counsel: Levine Keszler (Serge Levine, Rebecca Zbili, Pierre-Alexandre Diaz del Castillo)
UK transactional counsel and due diligence: Keystone Law (Jeremy Davis, Sophie Welbourn, Rupert Casey, Emma Wayland)
US transactional counsel and due diligence: Manatt, Phelps & Phillips, LLP San Francisco (Richard McDerby, Michel Narganes, John Heber)
Indian transactional counsel and due diligence: S&R Associates, New Delhi (Rajat Sethi, Lakshmi Pradeep, Rishabh Uppal, Pradhumna Mohan Dixit)
French labor law due diligence: DJS Avocats (Camille Smadja, Levana Chemla)
Financial due diligence: Advance Capital (Sophie Gosselin, Églantine Emery, Clément Delahousse)

Advisors for Calyx:
Global legal counsel: Bryan Cave Leighton Paisner LLP, US, London & Paris (Marie Johnson, Xolani Ntamane, Manuela Ampontuah, Andrew Cromb, Benjamin Wheeler, Roland Montfort, Alexandre Gelblat)
M&A advisor: Crosstree Capital (Mat Merchel, Adam Johnston, Jason Layton)

Press Release: attached.